Home › Sudden Cardiac Arrest › NCT07778823
Augmented Reality-Cardiopulmonary Resuscitation Support for Pediatric Resuscitation
AR-CPR: Large-Scale Simulation-Based Testing of a Novel Augmented Reality Point of Care Chest Compression Feedback System
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Actively credentialed pediatric emergency department or pediatric intensive care unit nurse or clinical technician at a participating study site * Current American Heart Association (AHA) Pediatric Advanced Life Support (PALS) certification Exclusion Criteria: * Inability to physically perform chest compressions * Need for prescription corrective lenses without having those corrective lenses available at the time of study participation
About the study
This study evaluates whether an augmented reality cardiopulmonary resuscitation feedback system (AR-CPR) can support health care providers in delivering high-quality chest compressions during pediatric cardiac arrest. AR-CPR provides real-time visual feedback on chest compression rate, depth, and recoil through a head-mounted augmented reality display.
In this randomized, multicenter, international, simulation-based non-inferiority study, health care providers perform chest compressions during an 18-minute simulated pediatric cardiac arrest. Participants are assigned to receive either real-time feedback from AR-CPR or coaching from a trained human CPR coach. The primary objective is to determine whether the percentage of chest compressions meeting guideline targets for both rate and depth with AR-CPR is non-inferior to that achieved with human CPR coaching.
What is being tested
- AR-CPR (device)
Sponsor: Johns Hopkins University · Participants: 252 · Started: Jun 29, 2025
Contact the study team
- Keith Kleinman, MD · Phone: 410-955-5000
- Justin Jeffers, MD · Phone: 410-955-5000
Official record on ClinicalTrials.gov — NCT07778823
Locations in the U.S.
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.